News & Articles

Trends in biomarker discovery methods and novel techniques advancing research, clinical diagnostics and therapeutic development

All the talks and resources exploring the latest research and methods in the field are now available free and on demand - but for a limited time only

Watch this on-demand webinar to learn about the pathogenicity and transmission of Salmonella

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

The kit promises to be a low cost, high-sensitivity diagnostic test for COVID-19 detection

How the NanoDrop One UV-Vis Spectrophotometer is bringing specificity to UV-Vis measurements

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR

Improved assay reduces time to product release by detecting bacteria faster

Join us Monday, November 16, to explore the advantages and applications of direct molecular testing

Which new products made the most difference to your lab work this year?

Join this expert webinar on Thursday, October 29, to find out how to master your pipetting technique and increase lab efficiency

University of Connecticut (UConn) microbial ecologist Dr. Kendra Maas reveals how Ceres Nanosciences’ Nanotrap® particles have saved her invaluable time as she builds an ambitious COVID-19 tracking system

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

Learn the importance of low LoD tests and discover the most sensitive kits available, as determined by the FDA’s SARS-CoV-2 Reference Panel

Join us on Thursday, October 29, to learn about the crucial role of food authenticity testing

Find out how to rapidly test for multiple disease-causing microorganisms with syndromic panel-based testing

Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test

Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions

The new products are designed to offer enhanced usability with features designed for academic, commercial, and biopharma labs to conduct basic and translational research